These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26445605)

  • 41. The present status of surgery for lung cancer.
    Lacquet LK
    Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of adjuvant therapy in the management of pN2 non-small-cell carcinoma of the lung].
    Chella A; Lucchi M; Gragnani F; Ribechini A; Silvano G; Janni A; Mussi A; Angeletti CA
    Minerva Chir; 1995 Dec; 50(12):1029-38. PubMed ID: 8725059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System.
    D'Annoville T; D'Journo XB; Loundou A; Trousse D; Dahan L; Doddoli C; Seitz JF; Thomas PA
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e207-11; discussion e211. PubMed ID: 23818566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
    Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
    J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
    Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
    Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis.
    Liu WS; Zhao LJ; Wang S; Gong LL; Liu ZY; Yuan ZY; Wang P
    Eur J Surg Oncol; 2014 Sep; 40(9):1156-62. PubMed ID: 24655801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its Management.
    Varlotto JM; Emmerick I; Voland R; DeCamp MM; Flickinger JC; Maddox DJ; Herbert C; Griffin M; Rava P; Fitzgerald TJ; Oliveira P; Baima J; Sood R; Walsh W; McIntosh LJ; Lou F; Maxfield M; Rassaei N; Uy K
    Front Oncol; 2020; 10():417. PubMed ID: 32528866
    [No Abstract]   [Full Text] [Related]  

  • 56. Mediastinal radiotherapy after adjuvant chemotherapy for resected non-small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis.
    Harling L; Jayakumar S; Ashrafian H; Bille A; Toufektzian L; Smith D
    JTCVS Open; 2021 Mar; 5():121-130. PubMed ID: 36003173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Causation between Pathway Completion and Reduced Hospital Stay in Patients with Lung Cancer: a Retrospective Cohort Study Using Propensity Score Matching.
    Furuhata H; Araki K; Ogawa T
    J Med Syst; 2020 Apr; 44(6):105. PubMed ID: 32318867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of postoperative radiotherapy for completely resected pIIIA-N2 non-small cell lung cancer patients with different clinicopathological features: a systemic review and meta-analysis.
    Liu T; Mu Y; Dang J; Li G
    J Cancer; 2019; 10(17):3941-3949. PubMed ID: 31417638
    [No Abstract]   [Full Text] [Related]  

  • 59. Reappraisal of the role of postoperative radiation therapy in patients with pIIIa-N2 non-small cell lung cancer: A propensity score matching analysis.
    Cao Q; Zhang B; Zhao L; Wang C; Gong L; Wang J; Pang Q; Li K; Liu W; Li X; Wang P; Wang P
    Thorac Cancer; 2015 Sep; 6(5):570-8. PubMed ID: 26445605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of positive nodal chain ratio on individualized multimodality therapy in non-small-cell lung cancer.
    Cao Q; Zhang B; Zhao L; Wang C; Gong L; Wang J; Pang Q; Li K; Liu W; Li X; Wang P; Wang P
    Tumour Biol; 2015 Jun; 36(6):4617-25. PubMed ID: 25623115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.